Authors: Shanafelt, AB Lin, Y Shanafelt, MC Forte, CP DuboisStringfellow, N Carter, C Gibbons, JA Cheng, SI Delaria, KA Fleischer, R Greve, JM Gundel, R Harris, K Kelly, R Koh, B Li, Y Lantz, L Mak, P Neyer, L Plym, MJ Roczniak, S Serban, D Thrift, J Tsuchiyama, L Wetzel, M Wong, M Zolotorev, A

Citation: Ab. Shanafelt et al., A T-cell-selective interleukin 2 mutein exhibits potent antitumor activityand is well tolerated in vivo (vol 18, pg 1197, 2000), NAT BIOTECH, 18(12), 2000, pp. 1318-1318

Authors: Shanafelt, AB Lin, Y Shanafelt, MC Forte, CP Dubois-Stringfellow, N Carter, C Gibbons, JA Cheng, SI Delaria, KA Fleischer, R Greve, JM Gundel, R Harris, K Kelly, R Koh, B Li, Y Lantz, L Mak, P Neyer, L Plym, MJ Roczniak, S Serban, D Thrift, J Tsuchiyama, L Wetzel, M Wong, M Zolotorev, A

Citation: Ab. Shanafelt et al., A T-cell-selective interleukin 2 mutein exhibits potent antitumor activityand is well tolerated in vivo, NAT BIOTECH, 18(11), 2000, pp. 1197-1202

Authors: Sen Majumdar, A Zolotorev, A Samuel, S Tran, K Vertin, B Hall-Meier, M Antoni, BA Adeline, E Philip, M Philip, R

Citation: A. Sen Majumdar et al., Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model, CANC GENE T, 7(7), 2000, pp. 1086-1099